Insulin Sensitizers Role in Control of PCOS Vicious Cycle.
-
- STATUS
- Not Recruiting
-
- participants needed
- 210
-
- sponsor
- Zagazig University
Summary
PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS is highly associated with various metabolic and endocrinal disorders. Metformin is mainly used for its glucose-lowering effects for treatment and prevention of type-2 diabetes mellitus (DM), gestational DM, and PCOS. Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.
Details
| Condition | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries |
|---|---|
| Age | 18years - 45years |
| Treatment | metformin hydrochloride, MI/DCI combination in 40:1 ratio, Combination of Metformin hydrochloride and MI/DCI |
| Clinical Study Identifier | NCT06170463 |
| Sponsor | Zagazig University |
| Last Modified on | 29 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.